Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports.

Ali Al-JanabiAlexander M Marsland

Published in: Clinical case reports (2020)

Cutaneous adverse events to dupilumab can be varied; this necessitates keeping a broad differential diagnosis to identify seemingly paradoxical reactions. It may be possible to treat the adverse event concurrently without stopping dupilumab.

Keyphrases

atopic dermatitis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
emergency department
patient reported outcomes